Cost-effectiveness of smoking cessation to prevent age-related macular degeneration

被引:6
|
作者
Susan F Hurley
Jane P Matthews
Robyn H Guymer
机构
[1] Bainbridge Consultants,School of Medicine
[2] Griffith University,School of Population Health
[3] The University of Melbourne,Macular Research Unit, Department of Ophthalmology, Centre for Eye Research Australia
[4] The University of Melbourne,undefined
关键词
Chronic Obstructive Pulmonary Disease; Smoking Cessation; Ranibizumab; Macular Degeneration; Geographic Atrophy;
D O I
10.1186/1478-7547-6-18
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Cost-effectiveness of ranibizumab for neovascular age-related macular degeneration
    Hurley S.F.
    Matthews J.P.
    Guymer R.H.
    [J]. Cost Effectiveness and Resource Allocation, 6 (1)
  • [2] The cost-effectiveness of treatment of age-related macular degeneration: a review
    Kymes, Steven N.
    [J]. MINERVA MEDICA, 2009, 100 (01) : 69 - 77
  • [3] Screening for Age-Related Macular Degeneration: A Cost-Effectiveness Evaluation
    Gajdos, Ondrej
    Hola, Martina
    Kamensky, Vojtech
    Havelkova, Anna
    [J]. BIOINFORMATICS AND BIOMEDICAL ENGINEERING, PT II, IWBBIO 2024, 2024, 14849 : 31 - 41
  • [4] Cost-effectiveness of vitamin therapy for age-related macular degeneration
    Rein, David B.
    Saaddine, Jinan B.
    Wittenborn, John S.
    Wirth, Kathleen E.
    Hoerger, Thomas J.
    Narayan, K. M. Venkat
    Clemons, Traci
    Sorensen, Stephen W.
    [J]. OPHTHALMOLOGY, 2007, 114 (07) : 1319 - 1326
  • [5] Cost-effectiveness of intravitreal therapy in Age-Related Macular Degeneration
    Neri, Piergiorgio
    Arapi, Ilir
    Eandi, Chiara Maria
    Pirani, Vittorio
    Mariotti, Cesare
    Giovannini, Alfonso
    [J]. FARMECONOMIA-HEALTH ECONOMICS AND THERAPEUTIC PATHWAYS, 2014, 15 (04) : 129 - 138
  • [6] A COST-EFFECTIVENESS ANALYSIS OF THREE TREATMENTS FOR AGE-RELATED MACULAR DEGENERATION
    Gower, Emily W.
    Cassard, Sandra D.
    Bass, Eric B.
    Schein, Oliver D.
    Bressler, Neil M.
    [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2010, 30 (02): : 212 - 221
  • [7] Cost-Effectiveness Models in Age-Related Macular Degeneration: Issues and Challenges
    Schmier, Jordana K.
    Hulme-Lowe, Carolyn K.
    [J]. PHARMACOECONOMICS, 2016, 34 (03) : 259 - 272
  • [8] Cost-Effectiveness Models in Age-Related Macular Degeneration: Issues and Challenges
    Jordana K. Schmier
    Carolyn K. Hulme-Lowe
    [J]. PharmacoEconomics, 2016, 34 : 259 - 272
  • [9] The cost-effectiveness of systematic screening for age-related macular degeneration in South Korea
    Ho, Ra
    Song, Lina D.
    Choi, Jin A.
    Jee, Donghyun
    [J]. PLOS ONE, 2018, 13 (10):
  • [10] Cost-effectiveness of ranibizumab compared with pegaptanib in neovascular age-related macular degeneration
    Luis Javier Hernández-Pastor
    Ana Ortega
    Alfredo García-Layana
    Joaquín Giráldez
    [J]. Graefe's Archive for Clinical and Experimental Ophthalmology, 2010, 248 : 467 - 476